Neurocabapigin Capsule 50 mg (Pregabalin)

Adult dose

This medication is administered orally without regard to food, usually divided into two doses daily. 1. Neuropathic Pain 1) Peripheral Neuropathic Pain: The starting dose is 150 mg per day, which can be increased to 300 mg per day within 3 to 7 days. If necessary, it can be titrated up to a maximum of 600 mg per day at intervals of 7 days. 2) Central Neuropathic Pain: The starting dose is 150 mg per day.

Child dose

Administration is not recommended for pediatric patients under 12 years old and adolescents aged 12-17 due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behaviors; therefore, if any unusual changes in mood or behavior occur during treatment, consult a physician immediately. Do not take if allergic to any of the ingredients in this medication. Diabetic patients should be cautious as weight gain may require adjustments in blood glucose control medications. If symptoms of angioedema such as facial or oral swelling occur, stop taking the medication immediately and inform a physician. Elderly patients should be particularly careful in the early stages of taking this medication due to an increased risk of falls or injuries from dizziness or drowsiness. Transitory visual blurring or changes in vision may occur during treatment; these symptoms may improve upon discontinuation of the medication. When switching from other antiepileptic drugs to this medication, careful consideration is needed due to insufficient data on the subject. Abrupt discontinuation of the medication may lead to withdrawal symptoms such as insomnia, headache, nausea, anxiety, depression, and suicidal thoughts, so it should be tapered off according to a physician’s instructions. Patients with a history of substance abuse may have a higher risk of misuse of this medication, thus caution is advised during treatment. Patients with impaired kidney function may require dosage adjustments, and there have been reports of improvement in kidney function after dose reduction or discontinuation. Patients with heart or vascular diseases should use this medication with caution, especially those with congestive heart failure. Taking this medication with opioid analgesics may increase central nervous system depressive effects, leading to risks such as respiratory depression; careful monitoring is required. In the early stages of pregnancy, there is a risk of congenital malformations in the fetus, so it should not be taken during pregnancy without a physician’s judgment, and women of childbearing potential should use effective contraception. During breastfeeding, this medication may pass into breast milk, so careful consideration of the benefits of taking the medication versus breastfeeding is necessary. This medication may cause dizziness and drowsiness, so it is advisable to avoid driving or operating dangerous machinery after taking it. Serious allergic reactions may occur; if symptoms such as rash, blistering, or skin peeling develop, discontinue use immediately and consult healthcare personnel. Overdose may lead to confusion, drowsiness, depression, seizures, etc., and immediate medical attention should be sought.

Serious side effects

Hives, severe swelling (edema), angioedema, facial swelling, swelling around the mouth and upper airways, chest tightness, difficulty breathing, cold sweat, pallor, severe rashes with fever, blistering, skin peeling, pain in mucous membranes of mouth/eyes, Stevens-Johnson syndrome, toxic epidermal necrolysis, respiratory depression, difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), systemic symptoms

Mild side effects

• Dizziness
• drowsiness
• confusion
• impaired sense of direction
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

Store this medication in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 15 degrees and 30 degrees. This will help preserve the medication's efficacy and safety.

Appearance

A hard capsule with a navy blue upper part and a white lower part filled with white to pale yellow powder.

Package unit

30 capsules/bottle, 100 capsules/bottle